Australian Clinical Labs Ltd (ACL) — Net Asset Quality Index
Australian Clinical Labs Ltd (ACL) has a Net Asset Quality Index of 26.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of AU$562.50 Million minus total liabilities of AU$411.46 Million yields net assets of AU$151.04 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check ACL cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Australian Clinical Labs Ltd Net Asset Quality Index Over Time (2016–2025)
This chart shows how Australian Clinical Labs Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2016 to 2025. As of December 2025, the index stands at 26.9%, representing net assets of AU$151.04 Million against total assets of AU$562.50 Million AUD. See Australian Clinical Labs Ltd (ACL) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Australian Clinical Labs Ltd (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Australian Clinical Labs Ltd from 2016 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Australian Clinical Labs Ltd market capitalisation.
| Year | Quality Index | Net Assets (AUD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 29.9% | AU$171.98 Million | AU$574.84 Million | AU$402.86 Million | ▲ +0.0 pp |
| 2024 | 29.9% | AU$171.98 Million | AU$574.84 Million | AU$402.86 Million | ▼ -0.1 pp |
| 2024 | 30.0% | AU$177.76 Million | AU$593.06 Million | AU$415.30 Million | ▲ +0.0 pp |
| 2023 | 30.0% | AU$177.76 Million | AU$593.06 Million | AU$415.30 Million | ▲ +0.1 pp |
| 2023 | 29.8% | AU$172.67 Million | AU$578.91 Million | AU$406.24 Million | ▲ +0.0 pp |
| 2022 | 29.8% | AU$172.67 Million | AU$578.91 Million | AU$406.24 Million | ▼ -7.2 pp |
| 2022 | 37.0% | AU$232.56 Million | AU$628.04 Million | AU$395.49 Million | ▲ +0.0 pp |
| 2021 | 37.0% | AU$232.56 Million | AU$628.04 Million | AU$395.49 Million | ▲ +19.8 pp |
| 2021 | 17.3% | AU$81.91 Million | AU$474.70 Million | AU$392.79 Million | ▲ +0.0 pp |
| 2020 | 17.3% | AU$81.91 Million | AU$474.70 Million | AU$392.79 Million | ▼ -1.6 pp |
| 2020 | 18.8% | AU$68.99 Million | AU$366.05 Million | AU$297.06 Million | ▲ +0.0 pp |
| 2019 | 18.8% | AU$68.99 Million | AU$366.05 Million | AU$297.06 Million | ▲ +1.0 pp |
| 2019 | 17.9% | AU$27.42 Million | AU$153.61 Million | AU$126.19 Million | ▲ +0.0 pp |
| 2018 | 17.9% | AU$27.42 Million | AU$153.61 Million | AU$126.19 Million | ▲ +13.3 pp |
| 2018 | 4.6% | AU$5.46 Million | AU$119.06 Million | AU$113.60 Million | ▲ +0.0 pp |
| 2017 | 4.6% | AU$5.46 Million | AU$119.06 Million | AU$113.60 Million | ▼ -7.1 pp |
| 2017 | 11.7% | AU$14.12 Million | AU$120.89 Million | AU$106.77 Million | ▲ +0.0 pp |
| 2016 | 11.7% | AU$14.12 Million | AU$120.89 Million | AU$106.77 Million | — |